Parkinson Disease Treatment in Hospitals and Nursing Facilities: Avoiding Pitfalls
- 1 July 2014
- journal article
- review article
- Published by Elsevier in Mayo Clinic Proceedings
- Vol. 89 (7) , 997-1003
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Rasagiline, Parkinson neuroprotection, and delayed-start trialsNeurology, 2010
- Levodopa raises objective pain threshold in Parkinson's disease: a RIII reflex studyJournal of Neurology, Neurosurgery & Psychiatry, 2007
- Effect of levodopa on pain threshold in Parkinson's disease: A clinical and positron emission tomography studyMovement Disorders, 2005
- Dopamine receptor agonists in current clinical use: comparative dopamine receptor binding profiles defined in the human striatumJournal of Neural Transmission, 2003
- Slower progression of Parkinson's disease with ropinirole versus levodopa: The REAL‐PET studyAnnals of Neurology, 2003
- Pramipexole vs Levodopa as Initial Treatment for Parkinson DiseaseJAMA, 2000
- A Five-Year Study of the Incidence of Dyskinesia in Patients with Early Parkinson's Disease Who Were Treated with Ropinirole or LevodopaNew England Journal of Medicine, 2000
- New, Selective Catechol-O-Methyltransferase Inhibitors as Therapeutic Agents in Parkinson’s DiseasePharmacology & Therapeutics, 1999
- Slow recovery of human brain MAO B after L‐Deprenyl (Selegeline) withdrawalSynapse, 1994
- Controlled-Release Sinemet (CR-4): A Double-Blind Crossover Study in Patients With Fluctuating Parkinson's DiseaseMayo Clinic Proceedings, 1988